Uncategorized Archives - Page 51 of 65

The Authors’ Own Words: Interest in using mobile technology to help self-manage alcohol use among persons living with HIV: A Florida Cohort cross-sectional study

Dec 9, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Interest in using mobile technology to help self-manage alcohol use among persons living with HIV: A Florida Cohort cross-sectional study

J. Danielle Sharpe, MS; Zhi Zhou, DDS, MPH; César G. Escobar-Viera, MD, PhD; Jamie P. Morano, MD, MPH; Robert J. Lucero, PhD, MPH, RN; Gladys E. Ibañez, PhD; Mark Hart, EdD, MALS; Christa L. Cook, PhD, MSN, RN; & Robert L. Cook, MD, MPH

Substance Abuse Vol. 39, Iss. 1, 2018

“Our manuscript contributes to the literature in regards to informing the development of mobile technology-based interventions for persons living with HIV who have hazardous alcohol use issues. To the knowledge of my co-authors and I, no previous research has explored mobile technology usage and the interest of PLWH who drink to use mobile technology for alcohol-related health interventions, and our study is the first to explore this. Our study found that PLWH who drink demonstrated moderate mobile technology use and were fairly willing to use a cell phone app to manage alcohol use, indicating that a portion of PLWH who drink have the interest and technological capacity for a mobile technology-based intervention to reduce alcohol consumption. These findings will be useful to researchers who are designing mobile technology-based interventions aimed at helping PLWH self-manage their alcohol use behavior to improve their HIV health outcomes.”

The Authors’ Own Words: Increasing availability of benzodiazepines among people who inject drugs in a Canadian setting

Dec 9, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Increasing availability of benzodiazepines among people who inject drugs in a Canadian setting

Geoffrey Walton, MD; Huiru Dong, MSc; M. J. Milloy, PhD; Kora DeBeck, PhD; Thomas Kerr, PhD; Evan Wood, MD, PhD; & Kanna Hayashi, PhD

Substance Abuse Vol. 39, Iss. 1, 2018

“Among our large community-recruited sample of people who inject drugs in Vancouver, benzodiazepine availability has significantly increased between 2012 and 2015. We also found that incarceration, and engagement in methadone maintenance therapy were independently associated with more immediate access to benzodiazepines. These findings highlight the need to educate physicians and patients regarding the harms of benzodiazepine use in the groups identified and suggest that further research is needed to investigate the reasons behind these associations including where people who inject drugs are securing their benzodiazepines.”

The Authors’ Own Words: Alcohol, Marijuana, and Opioid Use Disorders: 5-Year Patterns and Characteristics of Emergency Department Encounters

Dec 8, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Alcohol, Marijuana, and Opioid Use Disorders: 5-Year Patterns and Characteristics of Emergency Department Encounters

Amber L. Bahorik, PhD; Derek D. Satre, PhD; Andrea H. Kline-Simon, MS; Constance M. Weisner, DrPH, MSW; Kelly C. Young-Wolff, PhD, MPH; & Cynthia I. Campbell, PhD

Substance Abuse Vol. 39, Iss. 1, 2018

“Our study highlights that emergency department (ED) settings offer critical opportunities for clinicians to identify and intervene on patients with alcohol, marijuana, and opioid use disorders to initiate treatment, with those who have opioid use disorders having the highest ED use and potentially the greatest treatment needs. Devoting more health resources to providing training for initiating ED-based treatments for patients who have opioid use disorders in heath-systems, such as ED-initiated buprenorphine and referral to substance use disorder treatment, may be a step toward improving health outcomes and reducing ED visits in this population.”

The Authors’ Own Words: Metabolic syndrome among patients with heroin use disorders on methadone therapy: prevalence, characteristics, and related factors

Dec 7, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Metabolic syndrome among patients with heroin use disorders on methadone therapy: prevalence, characteristics, and related factors

Gabriel Vallecillo, MD; María José Robles, MD; Marta Torrens, MD; Pilar Samos, RN; Albert Roquer, RN; Paula K. Martires, RN; Arantza Sanvisens, MPH; Roberto Muga, MD; & Juan Pedro-Botet, MD

Substance Abuse Vol. 39, Iss. 1, 2018

“The results of this observational study show an elevated prevalence of overweight and metabolic syndrome in individuals with heroin use disorder on methadone therapy. These findings have significant implications for clinicians due to the increasing number of individuals on long-term methadone therapy and the progressive aging of this population. Therefore, the prevention of obesity and the diagnosis of the metabolic syndrome should be included in the clinical routine of this population with the aim of reducing the risk of developing diabetes and cardiovascular diseases in the future.”